Effect of cadmium on cortisol production and 11β-hydroxysteroid dehydrogenase 2 expression by cultured human choriocarcinoma cells (JEG-3)

被引:24
作者
Ronco, Ana Maria [1 ]
Llaguno, Emanuel [1 ]
Epunan, Maria Jose [1 ]
Llanos, Miguel N. [1 ]
机构
[1] Univ Chile, Inst Nutr & Food Technol INTA, Lab Nutr & Metab Regulat, Santiago, Chile
关键词
Cadmium; 11; beta-HSD2; JEG-3; Cortisol; DNA methylation; GENOMIC DNA METHYLATION; BIRTH-WEIGHT; TYPE-2; ACTIVITY; METHYLTRANSFERASE ACTIVITY; GROWTH RESTRICTION; GENE-EXPRESSION; MECHANISMS; CARCINOGENESIS; PLACENTA; DISEASE;
D O I
10.1016/j.tiv.2010.07.003
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cadmium is a toxicant with known carcinogenic and endocrine disruptor effects. We have previously reported that prenatal exposure to cadmium may induce low birth weight which is associated to increased foetal exposure to glucocorticoids; both signals constitute "hallmarks" of developmental programming. Since the effect of cadmium on the glucocorticoid system of placental carcinogenic cells is unknown, in the present work, we studied the effect of acute low dose of cadmium on cortisol production and 11 beta-HSD2 expression and activity by cultured human choriocarcinoma cells (JEG-3). In addition, it was also evaluated whether those effects were related to the methylation index of the HSD11B2 gene, which can be regulated by epigenetic mechanisms. Cells were incubated with low cadmium dose (0.5 and 1 mu M) for 24 h and viability (MTT), cortisol production (EIA), 11 beta-HSD2 expression (qRT-PCR) and activity (radioassay), and methylation index of the HSD11B2 gene were determined. Results show lower cortisol concentrations in the incubation media of exposed cells, which were associated to increased 11 beta-HSD2 expression and activity and to a lower methylation index of the gene. These results suggest that cadmium-induced endocrine disruptor effects on JEG-3 cells could be mediated by changes in the methylation status of some target genes. (C) 2010 Elsevier Ltd. All lights reserved.
引用
收藏
页码:1532 / 1537
页数:6
相关论文
共 39 条
  • [1] Epigenetic regulation of 11β-hydroxysteroid dehydrogenase type 2 expression
    Alikhani-Koopaei, R
    Fouladkou, F
    Frey, FJ
    Frey, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08) : 1146 - 1157
  • [2] Epigenetics and environmental chemicals
    Baccarelli, Andrea
    Bollati, Valentina
    [J]. CURRENT OPINION IN PEDIATRICS, 2009, 21 (02) : 243 - 251
  • [3] Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11β-hydroxysteroid dehydrogenase type 2 in a sex-specific manner
    Baserga, Mariana
    Kaur, Rajwinderjit
    Hale, Merica A.
    Bares, Allyson
    Yu, Xing
    Callaway, Christopher W.
    McKnight, Robert A.
    Lane, Robert H.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2010, 299 (01) : R334 - R342
  • [4] Bhattacharyya MH., 2000, Molecular Biology and Toxicology of Metals, P1
  • [5] Dual function of 11β-hydroxysteroid dehydrogenase in placenta:: Modulating placental glucocorticoid passage and local steroid action
    Burton, PJ
    Waddell, BJ
    [J]. BIOLOGY OF REPRODUCTION, 1999, 60 (02) : 234 - 240
  • [6] Clark S. J., 1997, P151
  • [7] Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
    Esteller, M
    Herman, JG
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (01) : 1 - 7
  • [8] HYPOMETHYLATION DISTINGUISHES GENES OF SOME HUMAN CANCERS FROM THEIR NORMAL COUNTERPARTS
    FEINBERG, AP
    VOGELSTEIN, B
    [J]. NATURE, 1983, 301 (5895) : 89 - 92
  • [9] Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension
    Friso, Simonetta
    Pizzolo, Francesca
    Choi, Sang-Woon
    Guarini, Patrizia
    Castagna, Annalisa
    Ravagnani, Viviana
    Carletto, Antonio
    Pattini, Patrizia
    Corrocher, Roberto
    Olivieri, Oliviero
    [J]. ATHEROSCLEROSIS, 2008, 199 (02) : 323 - 327
  • [10] Altered DNA methylation: A secondary mechanism involved in carcinogenesis
    Goodman, JI
    Watson, RE
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 : 501 - 525